Thursday 20 February 2020
 
»
Tag
 
»
Shire

Takeda completes acquisition of Shire

Takeda Pharmaceutical Company Limited today announced the completion of its acquisition of Shire, becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan.    Takeda no

More…

Takeda completes acquisition of Shire

Takeda Pharmaceutical Company Limited today announced the completion of its acquisition of Shire, becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan.    Takeda no

More…

Drugmaker Shire to buy Baxalta for $32bn

Drugmaker Shire clinched its six-month pursuit of Baxalta International on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which firs

More…

Drugmaker Shire to buy Baxalta for $32bn

Drugmaker Shire clinched its six-month pursuit of Baxalta International on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which firs

More…

Drugmaker Shire bids $30bn for Baxalta

Drugmaker Shire said on Tuesday it was seeking to buy Baxalta, a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases. The London-listed group went public wit

More…

US drugmaker AbbVie offers $51bn for Shire

US drugmaker AbbVie raised its offer for London-listed hyperactivity and rare diseases specialist Shire to 30.1 billion pounds ($51.3 billion) on Tuesday, hoping to win over its reluctant target after three earlier offers were rejected.

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads